Board of Dr. Lal PathLabs recommends final dividend
25 - Apr - 2025 12:00 | 6 days ago
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 25 April 2025, inter alia, have recommended the final dividend of Rs 6 per equity Share (i.e. 60%) , subject to the approval of the shareholders.
Dr Lal Pathlabs consolidated net profit rises 83.20% in the March 2025 quarter
25 - Apr - 2025 12:00 | 6 days ago
Net profit of Dr Lal Pathlabs rose 83.20% to Rs 154.80 crore in the quarter ended March 2025 as against Rs 84.50 crore during the previous quarter ended March 2024. Sales rose 10.49% to Rs 602.60 crore in the quarter ended March 2025 as against Rs 545.40 crore during the previous quarter ended March 2024.
For the full year,net profit rose 36.18% to Rs 487.10 crore in the year ended March 2025 as against Rs 357.70 crore during the previous year ended March 2024. Sales rose 10.55% to Rs 2461.40 crore in the year ended March 2025 as against Rs 2226.60 crore during the previous year ended March 2024.
Dr Lal Pathlabs consolidated net profit rises 83.20% in the March 2025 quarter
25 - Apr - 2025 12:00 | 6 days ago
Net profit of Dr Lal Pathlabs rose 83.20% to Rs 154.80 crore in the quarter ended March 2025 as against Rs 84.50 crore during the previous quarter ended March 2024. Sales rose 10.49% to Rs 602.60 crore in the quarter ended March 2025 as against Rs 545.40 crore during the previous quarter ended March 2024.
For the full year,net profit rose 36.18% to Rs 487.10 crore in the year ended March 2025 as against Rs 357.70 crore during the previous year ended March 2024. Sales rose 10.55% to Rs 2461.40 crore in the year ended March 2025 as against Rs 2226.60 crore during the previous year ended March 2024.
Board of Dr. Lal PathLabs recommends final dividend
25 - Apr - 2025 12:00 | 6 days ago
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 25 April 2025, inter alia, have recommended the final dividend of Rs 6 per equity Share (i.e. 60%) , subject to the approval of the shareholders.
Dr Lal Pathlabs consolidated net profit rises 83.20% in the March 2025 quarter
25 - Apr - 2025 12:00 | 6 days ago
Net profit of Dr Lal Pathlabs rose 83.20% to Rs 154.80 crore in the quarter ended March 2025 as against Rs 84.50 crore during the previous quarter ended March 2024. Sales rose 10.49% to Rs 602.60 crore in the quarter ended March 2025 as against Rs 545.40 crore during the previous quarter ended March 2024.
For the full year,net profit rose 36.18% to Rs 487.10 crore in the year ended March 2025 as against Rs 357.70 crore during the previous year ended March 2024. Sales rose 10.55% to Rs 2461.40 crore in the year ended March 2025 as against Rs 2226.60 crore during the previous year ended March 2024.
Board of Dr. Lal PathLabs recommends final dividend
25 - Apr - 2025 12:00 | 6 days ago
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 25 April 2025, inter alia, have recommended the final dividend of Rs 6 per equity Share (i.e. 60%) , subject to the approval of the shareholders.
Dr Lal Pathlabs consolidated net profit rises 83.20% in the March 2025 quarter
25 - Apr - 2025 12:00 | 6 days ago
Net profit of Dr Lal Pathlabs rose 83.20% to Rs 154.80 crore in the quarter ended March 2025 as against Rs 84.50 crore during the previous quarter ended March 2024. Sales rose 10.49% to Rs 602.60 crore in the quarter ended March 2025 as against Rs 545.40 crore during the previous quarter ended March 2024.
For the full year,net profit rose 36.18% to Rs 487.10 crore in the year ended March 2025 as against Rs 357.70 crore during the previous year ended March 2024. Sales rose 10.55% to Rs 2461.40 crore in the year ended March 2025 as against Rs 2226.60 crore during the previous year ended March 2024.
Dr Lal Pathlabs consolidated net profit rises 83.20% in the March 2025 quarter
25 - Apr - 2025 12:00 | 6 days ago
Net profit of Dr Lal Pathlabs rose 83.20% to Rs 154.80 crore in the quarter ended March 2025 as against Rs 84.50 crore during the previous quarter ended March 2024. Sales rose 10.49% to Rs 602.60 crore in the quarter ended March 2025 as against Rs 545.40 crore during the previous quarter ended March 2024.
For the full year,net profit rose 36.18% to Rs 487.10 crore in the year ended March 2025 as against Rs 357.70 crore during the previous year ended March 2024. Sales rose 10.55% to Rs 2461.40 crore in the year ended March 2025 as against Rs 2226.60 crore during the previous year ended March 2024.